Health
Asian nations scale back AstraZeneca rollout amid safety woes – The Japan Times
The moves may delay protection for the region amid concerns that the shot could trigger a rare and potentially deadly blood clotting condition.
Countries across the Asia Pacific are demurring on AstraZeneca PLCs COVID-19 vaccine, or restricting its use, in moves that may delay protection for the region amid concerns that the shot could trigger a rare and potentially deadly blood clotting condition.
After guiding against the vaccines use in people under 50 and saying that it didnt expect shipments from Europe to arrive on time, Australias government abandoned a pledge that everyone in the country would receive a first dose by October.
In…
-
Noosa News12 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
General21 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply
-
Noosa News24 hours agoGirl charged with attempted murder after foster carer stabbed in Ipswich
-
General22 hours agoSharp rise in airfares push UK inflation higher in July